Additionally, they suppress pro-inflammatory cytokine production (IL-6, TNF-α) via NF-κB pathway inhibition, reducing the inflammatory environment that promotes keloid growth (Huang et al., 2019; Kang et al., 2024). The gene discussed is TNF; the disease is keloid.